Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
153
NCT02151643
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Phase: Phase 2
Role: Lead Sponsor
Start: May 7, 2014
Completion: Mar 18, 2015